Proshares UltraPro Nasdaq Biotechnology (UBIO) declined -7.54% or -2.02 to $24.73. It is close to 40320 shares traded, which is 52.22% compare to the average total volume 77216. The market cap of UBIO is $28.44 million. The year to date change is -33.49%. The 52 week price range is from $23.94 to $46.35. Price of UBIO have changed 1.24% during last week. It have changed -18.68% over last month, -30.60% over last 3 months, -12.19% over last 6 months and -11.36% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBIO is 34.54. It is 39.67% above current price. The 200-day Moving Averages for UBIO is 34.93. It is 41.25% above current price. The 52-week High is 46.35. It is 87.42% from the current price. The 52-week Low is 23.94. It is -3.19% from current price.
There are some statistics of UBIO. It is has market cap $28.44 million. The share outstanding is 1.15 million. The average volume is 77216. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBIO is 3.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBIO is -3.19%.